Peter M Brennen1, Larry Kagemann, Thomas R Friberg. 1. UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Abstract
BACKGROUND AND OBJECTIVE: The Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) device is a spectral-domain optical coherence tomography system that allows faster data acquisition than the previous generation StratusOCT (Carl Zeiss Meditec, Dublin, CA), which is a time-domain device. The authors compared images from both units to determine the clinical usefulness of spectral-domain optical coherence tomography technology in patients with macular diseases. PATIENTS AND METHODS: Six consecutive patients were imaged with both the Cirrus HD-OCT and the StratusOCT devices and the images were compared. RESULTS: Cirrus HD-OCT images were typically more useful than StratusOCT images for assessing fine architectural details in macular pathology. The Cirrus HD-OCT software also facilitated a better understanding of three-dimensional data volumes. CONCLUSIONS: Commercially available spectral-domain optical coherence tomography is a clinically useful tool for visualizing and understanding macular diseases and offers benefits not inherent in previous generation machines.
BACKGROUND AND OBJECTIVE: The Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) device is a spectral-domain optical coherence tomography system that allows faster data acquisition than the previous generation StratusOCT (Carl Zeiss Meditec, Dublin, CA), which is a time-domain device. The authors compared images from both units to determine the clinical usefulness of spectral-domain optical coherence tomography technology in patients with macular diseases. PATIENTS AND METHODS: Six consecutive patients were imaged with both the Cirrus HD-OCT and the StratusOCT devices and the images were compared. RESULTS:Cirrus HD-OCT images were typically more useful than StratusOCT images for assessing fine architectural details in macular pathology. The Cirrus HD-OCT software also facilitated a better understanding of three-dimensional data volumes. CONCLUSIONS: Commercially available spectral-domain optical coherence tomography is a clinically useful tool for visualizing and understanding macular diseases and offers benefits not inherent in previous generation machines.
Authors: D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito Journal: Science Date: 1991-11-22 Impact factor: 47.728
Authors: Tony H Ko; James G Fujimoto; Joel S Schuman; Lelia A Paunescu; Andrew M Kowalevicz; Ingmar Hartl; Wolfgang Drexler; Gadi Wollstein; Hiroshi Ishikawa; Jay S Duker Journal: Ophthalmology Date: 2005-09-23 Impact factor: 12.079
Authors: C A Puliafito; M R Hee; C P Lin; E Reichel; J S Schuman; J S Duker; J A Izatt; E A Swanson; J G Fujimoto Journal: Ophthalmology Date: 1995-02 Impact factor: 12.079
Authors: Lisa S Schocket; Andre J Witkin; James G Fujimoto; Tony H Ko; Joel S Schuman; Adam H Rogers; Caroline Baumal; Elias Reichel; Jay S Duker Journal: Ophthalmology Date: 2006-04 Impact factor: 12.079
Authors: Vivek J Srinivasan; Maciej Wojtkowski; Andre J Witkin; Jay S Duker; Tony H Ko; Mariana Carvalho; Joel S Schuman; Andrzej Kowalczyk; James G Fujimoto Journal: Ophthalmology Date: 2006-11 Impact factor: 12.079